One of the primary challenges in using NRTIs is the development of drug resistance. HIV can rapidly mutate, and resistant strains can emerge that are less susceptible to the inhibitory effects of NRTIs. This necessitates the use of combination therapies, where multiple antiretroviral drugs with different mechanisms of action are used together to reduce the likelihood of resistance development.
